EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens

Zhiying Liu, Moyun Liu, Zichu Wang, Chenxiao Jiang, Jianfeng Wang iD, Xuming Deng, Hongtao Liu iD, Yanhong Deng iD, Jiazhang Qiu iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01196-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Zhiying Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Cardiolipins, Phosphatidylglycerols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treating multidrug-resistant (MDR) infections has become progressively dependent on limited therapeutic options, particularly polymyxins, such as colistin. This reliance has precipitated a concerning epidemiological trend: the emergence and global propagation of plasmid-mediated ( mcr ) as well as chromosome-mediated polymyxin resistance. Consequently, escalating resistance rates will certainly lead to diminished clinical efficacy of colistin, correlating with elevated mortality in septic patients who already face therapeutic limitations. Utilizing antimicrobial potentiators to restore the sensitivity of resistant pathogens to polymyxins represents a promising pharmacological strategy for reinvigorating the clinical utility of these agents. Here, we demonstrate that dronedarone hydrochloride (DH) exhibits significant synergistic bactericidal activity with colistin against colistin-resistant strains. DH enhances the antibacterial potency of colistin by approximately 32-fold (MIC from 8 μg/mL to 0.25 μg/mL in ExPEC ECQ001), effectively reversing resistance phenotypes. In vivo therapeutic efficacy studies demonstrated that combination therapy achieved a statistically significant reduction in bacterial burden compared to colistin therapy alone. Mechanistic studies revealed that DH has the capacity for specific molecular interactions with two critical phospholipid components: cardiolipin and phosphatidylglycerol (PG) in bacterial membranes. This binding induces membrane disruption, impairs energy production, and stimulates oxidative stress, which collectively augment the bactericidal activity of colistin. These findings position DH as a viable antibiotic adjuvant with translational potential for combination therapies against MDR pathogens. The dual targeting of membrane integrity and redox homeostasis presents a strategic advantage in circumventing conventional resistance mechanisms, thereby extending the application potential of colistin in contemporary antimicrobial regimens. IMPORTANCE Colistin remains a last resort antibiotic for treating infections caused by extensively drug-resistant pathogens. However, the emergence of colistin resistance has significantly compromised its clinical utility. Our research identifies and characterizes that dronedarone hydrochloride (DH) restores bacterial sensitivity to colistin by binding to cardiolipin (CL) and phosphatidylglycerol (PG). Mechanistic studies revealed that DH bound specifically to CL and PG, thereby enhancing membrane disruption, impairing energy production, and stimulating oxidative stress levels, which collectively augment the bactericidal activity of colistin. These findings present DH as a lead compound for combating colistin resistance, while offering novel mechanistic insights into its role as a colistin potentiator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinAnti-Bacterial AgentsCardiolipinsPhosphatidylglycerolsDronedaroneGram-Negative BacteriaMicrobial Sensitivity TestsAnimalsDrug SynergismMiceDrug Resistance, Multiple, BacterialHumans

Stichwörter der Autor:innen

antibiotic adjuvantantimicrobial resistancecolistindronedarone hydrochloride

Substanzen

ColistinAnti-Bacterial AgentsCardiolipinsPhosphatidylglycerolsDronedarone

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, Ch…

ORCID-Profile: Jianfeng Wang, Hongtao Liu, Yanhong Deng, Jiazhang Qiu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province
  • Fundamental Research Fund for the Central Universities

Zitieren

APA

Liu, Z., Liu, M., Wang, Z., Jiang, C., Wang, J., Deng, X., Liu, H., Deng, Y., & Qiu, J. (2025). Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01196-25

Vancouver

Liu Z, Liu M, Wang Z, Jiang C, Wang J, Deng X, et al. Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01196-25

BibTeX
@article{Liu2025,
  author = {Liu, Zhiying and Liu, Moyun and Wang, Zichu and Jiang, Chenxiao and Wang, Jianfeng and Deng, Xuming and Liu, Hongtao and Deng, Yanhong and Qiu, Jiazhang},
  title = {Dronedarone hydrochloride targets cardiolipin and phosphatidylglycerol to increase colistin susceptibility in gram-negative pathogens},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01196-25}
}
Kostenlos starten →